Top compounds associated with response to LINC00675


Feature Type Standardized
Nominal ANOVA
mRNA PI-103 CTRPv2 pan-cancer AAC -0.12 0.002
mRNA CHEMBL1222381 CTRPv2 pan-cancer AAC 0.11 0.002
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.003
mRNA PHA-665752 CCLE pan-cancer AAC 0.15 0.003
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.1 0.003
mRNA tosedostat CTRPv2 pan-cancer AAC -0.12 0.004
mRNA BYL-719 CTRPv2 pan-cancer AAC 0.14 0.004
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.004
mRNA 17-AAG CCLE pan-cancer AAC 0.14 0.004
mRNA PLX4720 CTRPv2 pan-cancer AAC -0.11 0.004
Download CSV